Form D · Biotechnology
INQ Biosciences,Inc.
Huntsville, AL · CIK 0001496791
Offering snapshot reported Jul 26, 2010 · SEC filing
- Reported sold
- $510K Offering amount: $595K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 2, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 26, 2010 | Initial | $510,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-145476
Source: Form D, filed Jul 26, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Cooper | Director |
| Aaron Hammons | Director, Executive |
| Milton Harris | Director |
| Reeves E. Richard | Director, Executive |
| Robert Thurber | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
515 Sparkman Drive
Huntsville, AL, 35816
Huntsville, AL, 35816